The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Surveillance for Recurrent Bladder Cancer Using a Point-of-Care Proteomic Assay
Abstract
CONTEXT: At least 50% of patients with a history of bladder cancer have recurrences, so rigorous surveillance is necessary. Cystoscopy is standard but can fail to detect some bladder cancers, so a urine test is frequently part of the evaluation. OBJECTIVE: To investigate whether a point-of-care proteomic test that measures the nuclear matrix protein NMP22 in voided urine could improve detection of recurrence during monitoring of patients with a history of bladder cancer. DESIGN, SETTING, AND PATIENTS: From September 2001 to February 2002, 23 academic, private practice, and hospital facilities in 9 US states prospectively enrolled 668 consecutive patients with a history of bladder cancer in this cross-sectional study. Patients provided a voided urine sample for analysis of NMP22 protein and cytology prior to cystoscopy. MAIN OUTCOME MEASURES: Diagnosis of bladder cancer recurrence, based on cystoscopy with biopsy, was accepted as the reference standard. The performance of the NMP22 test was compared with voided urine cytology as an aid to detection. Testing for the NMP22 tumor marker was conducted in a blinded manner. RESULTS: Bladder cancer was diagnosed in 103 patients. Cystoscopy alone identified 91.3% of the cancers (94/103; 95% confidence interval [CI], 84.1%-95.9%). The combination of cystoscopy with the NMP22 assay detected 99.0% of the malignancies (102/103; 95% CI, 94.7%-100%; P = .005). The NMP22 assay detected 8 of 9 cancers that were not visualized during initial cystoscopy, including 7 that were high-grade. The sensitivity and specificity of the NMP22 test alone were 49.5% (51/103; 95% CI, 39.5%-59.5%) and 87.3% (493/565; 95% CI, 84.2%-89.9%), respectively. Voided cytology detected only 3 of the malignancies missed during initial cystoscopy and did not significantly increase the sensitivity of cystoscopy (94.2%; 95% CI, 87.7%-97.8%; P = .08). CONCLUSION: The noninvasive point-of-care assay for elevated urinary NMP22 protein can increase the ability to detect recurrent bladder cancer, with test results available during the patient visit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Identification of a nuclear protein matrix
Berezney, R., & Coffey, D. S. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90355-6 · Cited by 996
Superficial Bladder Cancer: Progression and Recurrence
Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D., Hawkins, I. R., & For National Bladder Cancer Collaborative Group A S002253471751695X-1bb6d6502e02ba4ea1210f9f5bd6022d George R. Prout The principal investigators and institutions that contributed to the study are, M. G. H. (1983) · Journal of Urology · doi:10.1016/s0022-5347(17)51695-x · Cited by 924
The health economics of bladder cancer: A comprehensive review of the published literature
Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B., & Hauser, R. (2003) · PharmacoEconomics · doi:10.1007/bf03262330 · Cited by 860
A fixed site of DNA replication in eucaryotic cells
Pardoll, D. M., Vogelstein, B., & Coffey, D. S. (1980) · Cell · doi:10.1016/0092-8674(80)90527-9 · Cited by 655
Mapping replicational sites in the eucaryotic cell nucleus.
Nakayasu, H., & Berezney, R. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.1.1 · Cited by 520
Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin Fluorescence
Kriegmair, M., Baumgartner, R., Knuchel, R., Stepp, H., Hofstadter, F., & Hofstetter, A. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66559-5 · Cited by 434
Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay
Grossman, H. B. (2005) · JAMA · doi:10.1001/jama.293.7.810 · Cited by 367
Self-citationJOCHAM, D., WITJES, F., WAGNER, S., ZEYLEMAKER, B., van MOORSELAAR, J., GRIMM, M.-O., MUSCHTER, R., POPKEN, G., KöNIG, F., KNüCHEL, R., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000169257.19841.2a · Cited by 336
SÁNCHEZ-ORTIZ, R. F., HUANG, W. C., MICK, R., VAN ARSDALEN, K. N., WEIN, A. J., & MALKOWICZ, S. B. (2003) · Journal of Urology · doi:10.1016/s0022-5347(05)64047-5 · Cited by 261
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Babjuk, M., Burger, M., Zigeuner, R., Shariat, S. F., van Rhijn, B. W. G., Compérat, E., Sylvester, R. J., Kaasinen, E., Böhle, A., Palou Redorta, J., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.06.003 · Cited by 1,174
Human body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges
Mendelson, K., & Schoen, F. J. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-006-9163-z · Cited by 328
Clark, P. E., Agarwal, N., Biagioli, M. C., Eisenberger, M. A., Greenberg, R. E., Herr, H. W., Inman, B. A., Kuban, D. A., Kuzel, T. M., Lele, S. M., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0059 · Cited by 317
Metadata
- Authors
- Grossman, H. B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-01-18
- Volume
- 295
- Issue
- 3
- Pages
- 299
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2107929202
- Cited by
- 265
- References
- 18
- FWCI
- 26.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surveillance for Recurrent Bladder Cancer Using a Point-of-Care Proteomic Assay. https://app.cochat.ai/papers/10.1001/jama.295.3.299
- The paper
- Grossman, H. B. (2006). Surveillance for Recurrent Bladder Cancer Using a Point-of-Care Proteomic Assay. JAMA. https://doi.org/10.1001/jama.295.3.299
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.